Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies-Reference-Cited by-同舟云学术

Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies

Published:2022-03-22 Issue:6 Volume:111 Page:1248-1257
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Islam Nehal¹²,Ayele Henok T.¹²,Yu Oriana H. Y.²³,Douros Antonios¹²⁴⁵,Filion Kristian B.¹²⁴

Affiliation:

1. Department of Epidemiology, Biostatistics and Occupational Health McGill University Montréal Québec Canada

2. Center for Clinical Epidemiology Lady Davis InstituteJewish General Hospital Montréal Québec Canada

3. Division of Endocrinology Jewish General Hospital Montréal Québec Canada

4. Department of Medicine McGill University Montréal Québec Canada

5. Institute of Clinical Pharmacology and Toxicology Charité – Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2570

Reference40 articles.

1. A study of the effects of hypoglycemic agents on vascular complications in patients with adult‐onset diabetes. II. Mortality results;Meinert C.L.;Diabetes,1970

2. Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence

3. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy

4. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study

5. Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in small-molecule insulin secretagogues for diabetes treatment;Biomedicine & Pharmacotherapy;2024-09

2. Effect of different hypoglycemic drugs and insulin on the risk of new-onset atrial fibrillation in people with diabetes: a network meta-analysis;European Journal of Medical Research;2024-07-31

3. Combination of rare sugars L-arabinose, D-mannose, D-xylose, D-allulose, and D-tagatose alleviates cognitive impairment in mice with type 2 diabetes mellitus;2024-07-22

4. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review;Diabetes Therapy;2024-06-27

5. Sudden cardiac death due to ventricular arrhythmia in diabetes mellitus: A bench to bedside review;Heart Rhythm;2024-06